Conference Coverage

Tension, Other Headache Types Robustly Linked to Attempted, Completed Suicide


 

FROM AAN 2024

Ask About Mood

The results underscore the need for psychiatric evaluations in patients with a headache disorder. “For me, this is just going to make me that much more likely to ask my patients about their mood when I see them in clinic,” Dr. Elser said.

After asking patients with headache about their mood and stress at home and at work, physicians should have a “low threshold to refer to a behavioral health provider,” she added.

Future research should aim to better understand the link between headache and suicide risk, with a focus on the mechanisms behind low- and high-risk subgroups, said Dr. Elser.

A limitation of the study was that headache diagnoses were based on inpatient, emergency department, and outpatient specialist visits but not on visits to primary care practitioners. The study didn’t include information on headache severity or frequency and included only people who sought treatment for their headaches.

Though it’s unlikely the results “are perfectly generalizable” with respect to other geographical or cultural contexts, “I don’t think this relationship is unique to Denmark based on the literature to date,” Dr. Elser said.

Commenting on the study, session co-chair Todd J. Schwedt, MD, professor of neurology, Mayo Clinic Arizona, Phoenix, and president-elect of the American Headache Society, noted that the study offers important findings “that demonstrate the enormous negative impact that headaches can exert.”

It’s “a strong reminder” that clinicians should assess the mental health of their patients with headaches and offer treatment when appropriate, he said.

The study received support from Aarhus University. No relevant conflicts of interest were reported.

A version of this article appeared on Medscape.com.

Pages

Recommended Reading

Atogepant Effective and Safe in Pretreated Episodic Migraine, Shows Phase 3 Study
Migraine ICYMI
OnabotulinumtoxinA Reduces Interictal Burden and Allodynia Severity in Chronic Migraine
Migraine ICYMI
Comparing Efficacy and Safety of Atogepant and Rimegepant for Migraine Prevention
Migraine ICYMI
Erenumab May Worsen Hypertension in Patients with Migraine
Migraine ICYMI
Increased Headache Burden With Left vs Right-Sided Migraine
Migraine ICYMI
Higher Prevalence of Migraine in Women with Inflammatory Bowel Disease
Migraine ICYMI
Endometriosis and Concomitant Migraine Tied to Severe Pain and Disability
Migraine ICYMI
Long-term Fremanezumab Effective and Safe in Hard-to-Treat Migraine
Migraine ICYMI
Risk Factors for Headache in Youth Identified
Migraine ICYMI
Commentary: Migraine and Cardiovascular Risk, April 2024
Migraine ICYMI